233 related articles for article (PubMed ID: 14707029)
1. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.
Leggett JD; Aspley S; Beckett SR; D'Antona AM; Kendall DA; Kendall DA
Br J Pharmacol; 2004 Jan; 141(2):253-62. PubMed ID: 14707029
[TBL] [Abstract][Full Text] [Related]
2. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
3. Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor.
Steffens M; Zentner J; Honegger J; Feuerstein TJ
Biochem Pharmacol; 2005 Jan; 69(1):169-78. PubMed ID: 15588725
[TBL] [Abstract][Full Text] [Related]
4. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
Eldeeb K; Leone-Kabler S; Howlett AC
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
[TBL] [Abstract][Full Text] [Related]
5. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
[TBL] [Abstract][Full Text] [Related]
6. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
Cheer JF; Cadogan AK; Marsden CA; Fone KC; Kendall DA
Neuropharmacology; 1999 Apr; 38(4):533-41. PubMed ID: 10221757
[TBL] [Abstract][Full Text] [Related]
7. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
Hoi PM; Hiley CR
Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V
Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186
[TBL] [Abstract][Full Text] [Related]
9. Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.
Chen W; Tang H; Liu H; Long L; Gong Z; Zheng J; Chi M; Xie Y; Zheng Z; Li S; Wang L
Eur J Pharmacol; 2010 Jul; 637(1-3):178-85. PubMed ID: 20380831
[TBL] [Abstract][Full Text] [Related]
10. Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum.
Wang X; Horswill JG; Whalley BJ; Stephens GJ
Mol Pharmacol; 2011 Apr; 79(4):758-67. PubMed ID: 21189269
[TBL] [Abstract][Full Text] [Related]
11. Statistical Parametric Mapping reveals ligand and region-specific activation of G-proteins by CB1 receptors and non-CB1 sites in the 3D reconstructed mouse brain.
Nguyen PT; Selley DE; Sim-Selley LJ
Neuroimage; 2010 Oct; 52(4):1243-51. PubMed ID: 20451624
[TBL] [Abstract][Full Text] [Related]
12. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
13. Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors.
Bauer M; Chicca A; Tamborrini M; Eisen D; Lerner R; Lutz B; Poetz O; Pluschke G; Gertsch J
J Biol Chem; 2012 Oct; 287(44):36944-67. PubMed ID: 22952224
[TBL] [Abstract][Full Text] [Related]
14. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
Hiley CR; Hoi PM
Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087
[TBL] [Abstract][Full Text] [Related]
15. A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices.
Maya-López M; Rubio-López LC; Rodríguez-Alvarez IV; Orduño-Piceno J; Flores-Valdivia Y; Colonnello A; Rangel-López E; Túnez I; Prospéro-García O; Santamaría A
Neurotox Res; 2020 Jan; 37(1):126-135. PubMed ID: 31286434
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal inhibition of G-protein signaling is induced by CB(1) cannabinoid and GABA(B) receptor interactions in rat hippocampal membranes.
Cinar R; Freund TF; Katona I; Mackie K; Szucs M
Neurochem Int; 2008 Jun; 52(8):1402-9. PubMed ID: 18407377
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.
Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF
Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.
Steffens M; Engler C; Zentner J; Feuerstein TJ
Br J Pharmacol; 2004 Apr; 141(7):1193-203. PubMed ID: 14993102
[TBL] [Abstract][Full Text] [Related]
19. The actions of benzophenanthridine alkaloids, piperonyl butoxide and (S)-methoprene at the G-protein coupled cannabinoid CB₁ receptor in vitro.
Dhopeshwarkar AS; Jain S; Liao C; Ghose SK; Bisset KM; Nicholson RA
Eur J Pharmacol; 2011 Mar; 654(1):26-32. PubMed ID: 21172340
[TBL] [Abstract][Full Text] [Related]
20. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
De Vry J; Denzer D; Reissmueller E; Eijckenboom M; Heil M; Meier H; Mauler F
J Pharmacol Exp Ther; 2004 Aug; 310(2):620-32. PubMed ID: 15140913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]